Literature DB >> 20697201

Life without geminin.

Dimitris Karamitros1, Panorea Kotantaki, Zoi Lygerou, Henrique Veiga-Fernandes, Vassilis Pachnis, Dimitris Kioussis, Stavros Taraviras.   

Abstract

The interplay of proliferation and differentiation is essential for normal development and organogenesis. Geminin is a cell cycle regulator which controls licensing of origins for DNA replication, safeguarding genomic stability. Geminin has also been shown to regulate cellular decisions of self-renewal versus commitment of neuronal progenitor cells. We discuss here our recent analysis of mice with conditional inactivation of the Geminin gene in the immune system. Our data indicate that Geminin is not indispensable for every cell division: in the absence of Geminin, development of progenitor T cells appears largely unaffected. In contrast, rapid cell divisions, taking place in vitro upon TCR receptor activation or in vivo during homeostatic proliferation, are defective.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697201      PMCID: PMC3041160          DOI: 10.4161/cc.9.16.12554

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

1.  Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities.

Authors:  Elaine Stead; Josephine White; Renate Faast; Simon Conn; Sherilyn Goldstone; Joy Rathjen; Urvashi Dhingra; Peter Rathjen; Duncan Walker; Stephen Dalton
Journal:  Oncogene       Date:  2002-11-28       Impact factor: 9.867

Review 2.  Geminin in embryonic development: coordinating transcription and the cell cycle during differentiation.

Authors:  Kristen L Kroll
Journal:  Front Biosci       Date:  2007-01-01

Review 3.  Geminin's double life: chromatin connections that regulate transcription at the transition from proliferation to differentiation.

Authors:  Seongjin Seo; Kristen L Kroll
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

4.  ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication.

Authors:  Jie Jessie Lin; Anindya Dutta
Journal:  J Biol Chem       Date:  2007-08-22       Impact factor: 5.157

5.  A p53-dependent checkpoint pathway prevents rereplication.

Authors:  Cyrus Vaziri; Sandeep Saxena; Yesu Jeon; Charles Lee; Kazutaka Murata; Yuichi Machida; Nikhil Wagle; Deog Su Hwang; Anindya Dutta
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

6.  The replicative regulator protein geminin on chromatin in the HeLa cell cycle.

Authors:  Monika Kulartz; Rolf Knippers
Journal:  J Biol Chem       Date:  2004-07-28       Impact factor: 5.157

7.  The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall.

Authors:  T Takahashi; R S Nowakowski; V S Caviness
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

8.  Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity.

Authors:  Motoaki Ohtsubo; Shin'ichiro Yasunaga; Yoshinori Ohno; Miyuki Tsumura; Satoshi Okada; Nobutsune Ishikawa; Kenichiro Shirao; Akira Kikuchi; Hideo Nishitani; Masao Kobayashi; Yoshihiro Takihara
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

9.  Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development.

Authors:  Michael A Gonzalez; Kiku-e K Tachibana; David J Adams; Louise van der Weyden; Myriam Hemberger; Nicholas Coleman; Allan Bradley; Ronald A Laskey
Journal:  Genes Dev       Date:  2006-07-15       Impact factor: 11.361

10.  Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation.

Authors:  K L Kroll; A N Salic; L M Evans; M W Kirschner
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  7 in total

Review 1.  Controlling centriole numbers: Geminin family members as master regulators of centriole amplification and multiciliogenesis.

Authors:  Marina Arbi; Dafni-Eleftheria Pefani; Stavros Taraviras; Zoi Lygerou
Journal:  Chromosoma       Date:  2017-12-14       Impact factor: 4.316

Review 2.  Regulation of geminin by neuropeptide Y in vascular smooth muscle cell proliferation : A current review.

Authors:  S-Y Liang; Y-L Zhou; M-Q Shu; S Lin
Journal:  Herz       Date:  2018-08-27       Impact factor: 1.443

3.  Different effects of neuropeptide Y on proliferation of vascular smooth muscle cells via regulation of Geminin.

Authors:  Zhou-Qin Jiang; You-Li Zhou; Xia Chen; Lin-Yu Li; Shi-Yu Liang; Shu Lin; Mao-Qin Shu
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

4.  Varying outcomes of triple-negative breast cancer in different age groups-prognostic value of clinical features and proliferation.

Authors:  H Vihervuori; K Korpinen; T A Autere; H Repo; K Talvinen; P Kronqvist
Journal:  Breast Cancer Res Treat       Date:  2022-10-19       Impact factor: 4.624

5.  DNA Replication Inhibitor Geminin and Retinoic Acid Signaling Participate in Complex Interactions Associated With Pluripotency.

Authors:  Spyridon Champeris Tsaniras; George J Delinasios; Michalis Petropoulos; Andreas Panagopoulos; Athanasios K Anagnostopoulos; Maria Villiou; Dimitrios Vlachakis; Vasiliki Bravou; Georgios T Stathopoulos; Stavros Taraviras
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

6.  Overexpression of UHRF1 promoted the proliferation of vascular smooth cells via the regulation of Geminin protein levels.

Authors:  Xia Chen; You-Li Zhou; Shi-Yu Liang; Yan-Chuan Shi; Shu Lin; Mao-Qin Shu
Journal:  Biosci Rep       Date:  2019-02-26       Impact factor: 3.840

7.  The Geminin and Idas coiled coils preferentially form a heterodimer that inhibits Geminin function in DNA replication licensing.

Authors:  Christophe Caillat; Dafni-Eleftheria Pefani; Peter J Gillespie; Stavros Taraviras; J Julian Blow; Zoi Lygerou; Anastassis Perrakis
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.